Supraclavicular decompression for neurogenic thoracic outlet syndrome in adolescent and adult populations  by Caputo, Francis J. et al.
From the Society for Vascular Surgery
Supraclavicular decompression for neurogenic
thoracic outlet syndrome in adolescent and adult
populations
Francis J. Caputo, MD,a Anna M. Wittenberg, MPH,a Chandu Vemuri, MD,a
Matthew R. Driskill, MSPT,b Jeanne A. Earley, PT, MHS,b Rahul Rastogi, MD,c Valerie B. Emery, RN,a
and Robert W. Thompson, MD,a,d St. Louis, Mo
Objective: This study was conducted to better define clinical results and understand factors determining responsiveness to
surgical treatment for neurogenic thoracic outlet syndrome (NTOS) in adolescent and adult populations.
Methods: A retrospective review was conducted for 189 patients with disabling NTOS who underwent primary
supraclavicular decompression (scalenectomy, brachial plexus neurolysis and first rib resection, with or without pectoralis
minor tenotomy) from April 2008 to December 2010. Clinical characteristics were compared between 35 adolescent
patients (aged <21 years) and 154 adults (aged >21 years). Functional outcome measures were assessed before surgery
and at 3- and 6-month follow-up using a composite NTOS Index combining the Disabilities of the Arm, Shoulder and
Hand (DASH) survey, the Cervical-Brachial Symptom Questionnaire (CBSQ), and a 10-point visual analog scale (VAS)
for pain.
Results: Adolescent and adult patients were not significantly different with respect to sex (overall 72.5% female), side
affected (58.7% right, 60.3% dominant limb), bony anomalies (23.3%), previous injury (55.6%), coexisting pain disorders
(11.1%), and positive responses to scalene muscle anesthetic blocks (95.6%). Compared with adults, adolescent patients
had a significantly (P < .05) lower incidence of depression (11.4% vs 41.6%), motor vehicle injury (5.7% vs 20.1%),
previous operations (11.4% vs 29.9%), preoperative use of opiate medications (17.1% vs 44.8%), and symptom duration
>2 years (24.2% vs 50.0%). Mean preoperative NTOS Index (scale 0-100) was significantly lower in adolescent vs adult
patients (46.5 3.6 vs 58.5 1.7; P .009), and hospital length of stay was 4.4 0.2 vs 4.9 0.1 days (P .03), but
the rate of postoperative complications was no different (overall, 4.2%). Although both groups exhibited significant
improvement in functional outcomemeasures at 3 and 6months, adolescent patients had significantly lower NTOS Index
(10.4  3.1 vs 39.3  3.3; P < .001) and use of opiate medications (11.4% vs 47.4%; P < .001) compared with adults.
Conclusions: Adolescents undergoing supraclavicular decompression for NTOS had more favorable preoperative charac-
teristics and enhanced 3-month and 6-month functional outcomes than adults. Further study is needed to delineate the
age-dependent and independent factors that promote optimal surgical outcomes for NTOS. (J Vasc Surg 2013;57:
149-57.)
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vNeurogenic thoracic outlet syndrome (NTOS) is a
relatively uncommon condition caused by compression and
irritation of the brachial plexus within the scalene triangle
or the subcoracoid space.1,2 NTOS most frequently occurs
in relatively young, active, and otherwise healthy individu-
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http://dx.doi.org/10.1016/j.jvs.2012.07.025ls, with a clinical presentation typified by symptoms of
ain, numbness, and paresthesia in the arm or hand, or
oth, along with reproducible exacerbation by overhead
ositioning of the upper extremity. Physical examination
onsistently reveals localized tenderness to palpation over
he supraclavicular or subcoracoid space, or both, with
eproduction of radiating upper extremity symptoms and
xacerbation of symptoms during positional upper extrem-
ty maneuvers. NTOS is often associated with a history of
eck or upper extremity injury, previous surgical and non-
urgical treatment approaches, and protracted delays in
iagnosis.
The symptoms of NTOS can progress to disability in
oung active persons in school or the prime of working life.
onservative management based on physical therapy is the
ainstay of initial treatment, along with muscle relaxants,
nti-inflammatory agents, and adjustments in workplace
rgonomic factors, but may not improve symptoms in
atients with substantial or longstanding disability. Surgical
reatment for NTOS may be recommended in this setting,
ut its role has often been controversial, due in part to
ariations in diagnosis, diversity in the populations treated,
se of different surgical approaches and techniques, and
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January 2013150 Caputo et allimited application of defined outcome metrics to assess
results. The factors determining outcomes for surgical
treatment of NTOS therefore remain incompletely under-
stood.
The purpose of this study was to better characterize
clinical results and understand factors determining respon-
siveness to surgical treatment for NTOS, by examining
patient characteristics and postoperative outcomes in a
series of adolescent and adult patients undergoing supra-
clavicular decompression at a high-volume referral center.
METHODS
This study was approved by the Human Research Pro-
tectionOffice (HRPO) atWashingtonUniversity, St Louis,
Missouri.
Patients. The study population consisted of patients
referred to the Washington University Center for Thoracic
Outlet Syndrome at Barnes-Jewish Hospital (St. Louis,
Mo) for evaluation and surgical treatment of NTOS be-
tween April 2008 and December 2010. Patients with arte-
rial or venous forms of TOS in the absence of disabling
NTOS were excluded from review, as were patients with
NTOS undergoing reoperative procedures or isolated pec-
toralis minor tenotomy (PMT). Detailed information re-
garding each patient was obtained from a prospectively
maintained database and summarized from office notes,
hospital records, imaging studies, operative findings, and
records from treating physicians and therapists.
Initial evaluation. Pretreatment assessment included
the history and physical examination relevant to NTOS and
review of any previous evaluations, imaging studies, and
electrophysiologic tests. The diagnosis of NTOS was made
predominantly by clinical criteria, as previously de-
scribed.2-4 Plain chest radiographs, magnetic resonance
angiography, and computed tomography angiography
studies were performed as indicated by clinical circum-
stances to identify bony abnormalities and to exclude vas-
cular types of TOS but were not routinely obtained. Elec-
trophysiologic testing was not specifically used to establish
a diagnosis of NTOS but was used selectively to exclude
peripheral neuropathies or cervical nerve root syndromes.
Contrast-enhanced vascular imaging studies were per-
formed in patients with NTOS who had arm swelling, a
pulsatile mass in the neck, or signs of arterial insufficiency,
to identify those with coexisting venous or arterial TOS.
Assessment instruments. All patients were asked to
complete the Disabilities of the Arm, Shoulder and Hand
(DASH) survey instrument, the Cervical-Brachial Symp-
tom Questionnaire (CBSQ), and a 10-point visual analog
scale (VAS) for pain.5-7 The DASH is a 30-item survey
scored on a 0-100 scale, designed and validated for use in a
variety of upper extremity musculoskeletal disorders to
quantify the degree of disability. The CBSQ is a 14-item
survey scored on a 0-120 scale, developed for evaluation of
patients with NTOS and related disorders to measure func-
tional disturbances resulting from performance of certain
activities. The VAS is a widely used standard method for
assessment of pain. Each of these instruments provides a somewhat different measure of patient-reported symptoms
nd disability.
Because previous studies have demonstrated that the
elationship between self-reported disability and actual
unctional performance varies significantly,8-10 we hypoth-
sized that combining scores from the DASH, CBSQ, and
AS might provide a more accurate “functional outcome”
easure for patients with NTOS. The results of the three
atient-reported instruments were thereby combined to
alculate an “NTOS Index” as a single composite measure
NTOS Index  (DASH  {0.83  CBSQ}  {10 
AS})/3], which was scored on a 0-100 scale with higher
umbers indicating a greater degree of disability.
Fluoroscopy-guided anterior scalene (ASM) or pecto-
alis minor (PM) muscle blocks, or both, with local anes-
hetic were frequently used to help reinforce the clinical
iagnosis of NTOS and to provide additional insight into
he likely responsiveness to treatment.7,11 All patients not
reviously treated for NTOS and those for whom previous
hysical therapy did not appear to have been suitably tar-
eted toward NTOS, underwent a 4- to 6-week course of
TOS-specific physical therapy overseen by a therapist
ith experience and expertise in the management of
TOS.
Surgical treatment. Surgical treatment was offered
hen there was a sound clinical diagnosis of NTOS, a
ubstantial level of disability, and absence of significant
mprovement after a suitable course of NTOS-specific
hysical therapy. All patients for whom surgical treatment
as recommended therefore had disabling neurogenic
OS that had been refractory to previous attempts at
onservative management. The interval between initial
ymptoms and referral, the types and outcomes of previous
reatments, or the response to ASM/PM anesthetic blocks
id not preclude consideration for surgical treatment.
All patients underwent supraclavicular thoracic outlet
ecompression, including complete anterior and middle
calenectomy, resection of any aberrant fibromuscular
ands, mobilization and external neurolysis of all five bra-
hial plexus nerve roots, and first rib resection.2,12 If a
artial or complete cervical rib was present, it was also
ntirely resected. Patients that also had physical examina-
ion findings localized to the subcoracoid space underwent
oncomitant ipsilateral PMT through a vertical infraclavic-
lar (deltopectoral) incision; in selected patients with bilat-
ral symptoms, a contralateral PMT was also performed in
he same operative setting.13,14 Patients with NTOS and
oexisting signs or symptoms of venous TOS had an addi-
ional infraclavicular incision to permit paraclavicular resec-
ion of the first rib and direct subclavian vein reconstruction
f necessary, as previously described.15,16 Patients with
TOS and concomitant findings of arterial TOS also un-
erwent subclavian artery repair or distal arterial thrombo-
mbolectomy, or both, when indicated.
A closed-suction drain was placed in the neck at the end
f each procedure, and the brachial plexus was wrapped
ith an absorbable polylactide film (SurgiWrap; Mast Bio-
ciences Inc, MAST Biosurgery USA, San Diego, Calif) to
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Volume 57, Number 1 Caputo et al 151suppress development of perineural fibrosis. No patient
required division of the sternocleidomastoid muscle, partial
resection of the clavicle, disruption of the sternoclavicular
joint, or transmanubrial extension of the exposure. Hospi-
tal length of stay and the occurrence of any postoperative
complications requiring reoperation or a significant change
in management were recorded.
Postoperative follow-up. Postoperative physical ther-
apy was begun the day after surgical treatment to maintain
neck and upper extremity range of motion. Opiate pain med-
ications, a muscle relaxant, and an anti-inflammatory agent
were routinely administered. In the absence of complica-
tions, patients were discharged from the hospital as soon as
adequate pain control had been achieved solely on oral
medications with no nausea or constipation accompanying
opiate use, and the closed-suction drain was removed in the
outpatient setting during the first week after the operation.
Postoperative physical therapy was continued on a regular
schedule until at least 12 weeks, when unrestricted upper
extremity activity was permitted and discontinuation of
opiate medications encouraged. At a minimum, clinical
follow-up at 3 and 6 months after operation included
physical therapy evaluation, review of medications, and
completion of patient-reported functional outcome assess-
ment instruments.
Data analysis. The principal outcomes evaluated were
functional measures as assessed by the DASH, CBSQ, VAS,
and NTOS Index, including proportionate changes be-
tween preoperative status and each postoperative interval
and patient use and types of opiate pain medications. These
end points were then evaluated in relationship to patient
age and other clinical variables. Descriptive group data are
presented as the mean standard error of the mean or the
median and range of values for adolescent patients and
adults. The Pearson test was used for correlation analyses,
and comparisons between two groups were made using the
unpaired t-test with Welch correction (for data with con-
tinuous variables) or Fisher exact test (for categoric data).
For comparisons between more than two groups, one-way
analysis of variance (ANOVA) was used with the Newman-
Keuls multiple comparisons test (for data with continuous
variables). All statistical tests were performed using Prism
4.0c software (GraphPad Software Inc, San Diego, Calif),
with P  .05 considered significant.
RESULTS
Patient population and preoperative characteristics.
There were 189 patients that underwent primary surgical
treatment for NTOS between April 2008 and December
2010 and met the study criteria. As summarized in Table I,
there were 52 men (27.5%) and 137 women (72.5%), with
a mean age at the time of treatment of 35.8  0.9 years
(median, 37; range, 13-72 years). The age distribution of
patients included 35 (18.5%) aged 21 years and 154
(81.5%) aged 21 years, with the appearance of a bimodal
population distribution that distinguished adolescent
(mean age, 17.3  0.3; median, 17, range, 13-20 years) lrom adult patients (mean age, 40.0  0.7; median, 40;
ange, 22-72 years; Fig 1, A).
There were no significant differences between the ado-
escent and adult groups with respect to sex (overall, 72.5%
emale), side affected (58.7% right, 60.3% dominant limb),
ony anomalies (23.3%), previous injury (55.6%), or pres-
nce of coexisting pain disorders (11.1%; Table I). Com-
ared with adults, the adolescent patients had a significantly
ower incidence of depression (11.4% vs 41.6%) and history
f motor vehicle injury (5.7% vs 20.1%) and a higher
ncidence of repetitive motion injury (31.4% vs 14.9%) and
articipation in athletics (73% vs 8%). The overall frequency
nd extent of symptoms were similar for adolescent patients
nd adults as assessed for 38 different features potentially
ssociated with NTOS, with significant differences in sever-
ty (1-to-5 point numeric scale; 1  absent, 5  extreme)
xhibited only for hand pain (adolescent patients, 56%,
.3  0.2; adults, 79%, 2.9  0.1), hand cramping (ado-
able I. Preoperative characteristics of the study
opulation with thoracic outlet syndrome (TOS)
ariablea Adolescent Adult Pb
atients 35 (18.5) 154 (81.5)
ge, years
Mean  SEM 17.3  0.3 40.0  0.7 .0001
Median (range) 17 (13-20) 40 (22-72)
emale sex 26 (74.3) 111 (72.1) .05
ight-sided symptoms 22 (62.9) 89 (57.8) .05
ominant side affected 22 (63.0) 92 (59.7) .05
ony anomaly (eg,
cervical rib) 5 (14.3) 39 (25.3) .05
eurogenic TOS alone 31 (88.6) 136 (88.3) .05
 venous TOS 4 (11.4) 8 (5.2) .05
 arterial TOS 0 (0.0) 10 (6.5) .05
iagnosis of
Depression 4 (11.4) 64 (41.6) .0007
Other pain disorder 1 (2.9) 20 (13.0) .05
articipation in athletics 24 (72.7) 12 (8.3) .0001
istory of injury 22 (62.9) 83 (53.9) .05
Repetitive motion 11 (31.4) 23 (14.9) .0289
Motor vehicle
collision 2 (5.7) 31 (20.1) .0482
Fall on arm 7 (20.0) 25 (16.2) .05
Other 2 (5.7) 13 (8.4) .05
revious operations 4 (11.4) 46 (29.9) .0324
Cervical spine 0 (0.0) 20 (13.0) .0280
Shoulder 2 (5.7) 16 (10.4) .05
Cubital canal 0 (0.0) 10 (6.5) .05
Carpal tunnel 1 (2.9) 14 (9.1) .05
Other 1 (2.9) 2 (1.3) .05
Multiple operations 0 (0.0) 14 (9.1) .05
calene block
performed 15 (42.9) 99 (64.3) .0225
ositive scalene block 13 (86.7) 96 (97.0) .05
EM, Standard error of the mean.
Categoric data are shown as number (%) and continuous data as mean 
tandard error of the mean or median (range).
Comparison between adolescent (21 years of age) and adult (21 years
f age) groups, unpaired two-tailed t-test with Welch correction (for con-
inuous data) or Fisher exact test (for categoric data).escent patients, 41%, 1.9  0.2; adults, 63%, 2.4  0.1),
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January 2013152 Caputo et aland pale discoloration in the fingers (adolescent patients,
53%, 2.3  0.3; adults, 38%, 1.8  0.1; Table II). The
overall duration of symptoms before referral was shorter for
adolescent patients than for adults, with only 24.2% of
adolescent patents having symptoms 2 years compared
with 50% for adults (Fig 1, B).
Although all of the patients in this series were initially
evaluated and treated for neurogenic (brachial plexus)
symptoms, there were 12 (6.3%) with concomitant evi-
dence of positional subclavian vein obstruction (venous
Fig 1. Age distribution and duration of symptoms. A,
outlet syndrome is shown by age at presentation an
distinguishing adolescent (age21 years) from adult (ag
referral evaluation for neurogenic thoracic outlet syndr
patients. There was a significant difference between th
symptoms for 2 years (P  .007, 2 test), with no signTOS) and 10 (5.3%) with concomitant lesions of the sub- rlavian artery (arterial TOS), with no difference in the
resence of vascular obstruction between adolescent and
dult patients (Table I). Adolescent patients with NTOS
ad undergone fewer previous operations to treat the pre-
enting symptoms than adults (11.4% vs 29.9%), particu-
arly with respect to previous cervical spine procedures
0.0% vs 13.0%; Table I). Although scalene muscle blocks
ith local anesthetic were performed less frequently in the
dolescent group than in adults (42.9% vs 64.3%), there was
o difference between groups in the frequency of positive
distribution of 189 patients with neurogenic thoracic
gical treatment. A bimodal distribution is illustrated
years) patient groups. B,Duration of symptoms before
is shown in adolescent (n  35) and adult (n  154)
rcentage of adolescent vs adult patients that reported
t differences for the other time intervals.The
d sur
e21
ome
e peesponses (overall, 95.6%).
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mean preoperative DASH scores and CBSQ ratings were
significantly lower in the adolescent group than in adults
(DASH, 35.4  2.9 vs 49.7  1.7; CBSQ, 57.3  5.5 vs
Table II. Nature of preoperative symptomsa
Symptom (rank
order)
Adolescent Adult
Pb% Score % Score
Tingling/numbness,
hand 84 3.4  0.2 93 3.3  0.1 .05
Arm weakness 88 3.1  0.2 91 3.4  0.1 .05
Shoulder pain 84 3.4  0.2 90 3.4  0.1 .05
Arm pain 72 2.8  0.2 89 3.3  0.1 .05
Neck pain 81 2.9  0.2 87 3.2  0.1 .05
Hand weakness 78 2.8  0.2 88 3.2  0.1 .05
Tingling/
numbness, arm 78 3.1  0.3 86 3.0  0.1 .05
Awakening from
sleep 72 2.6  0.3 87 3.1  0.1 .05
Arm heaviness 71 2.5  0.2 79 2.9  0.1 .05
Hand pain 56 2.3  0.2 79 2.9  0.1 .0118
Trouble getting to
sleep 66 2.6  0.3 72 2.8  0.1 .05
Back pain 75 2.6  0.2 70 2.6  0.1 .05
Too sleepy during
day 59 2.4  0.3 72 2.6  0.1 .05
Cold feeling, hand 59 2.4  0.2 66 2.4  0.1 .05
Hand cramping 41 1.9  0.2 63 2.4  0.1 .0451
Muscle spasm, neck 47 2.0  0.2 55 2.3  0.1 .05
Cold feeling, arm 41 2.0  0.2 56 2.1  0.1 .05
Headaches, occipital 41 1.8  0.2 55 2.2  0.1 .05
Headaches, frontal 63 2.2  0.2 48 2.0  0.1 .05
Muscle spasm, arm 44 1.8  0.2 50 2.0  0.1 .05
Hand swelling 47 1.9  0.2 48 1.8  0.1 .05
Dyspnea with
exertion 44 1.9  0.2 46 1.9  0.1 .05
Muscle spasm, back 41 1.7  0.2 43 2.0  0.1 .05
Pale discoloration in
fingers 53 2.3  0.3 38 1.8  0.1 .0315
Arm swelling 41 1.7  0.2 38 1.7  0.1 .05
Side pain with
exertion 41 1.8  0.2 36 1.7  0.1 .05
Lump in neck 25 1.5  0.2 38 1.9  0.1 .05
Cyanotic hand
discoloration 47 1.9  0.2 32 1.6  0.1 .05
Neck swelling 16 1.3  0.1 32 1.6  0.1 .05
Vision changes 27 1.2  0.1 27 1.4  0.1 .05
Excess sweating,
hand 19 1.4  0.2 26 1.4  0.1 .05
Enlarged veins, arm 22 1.5  0.2 21 1.4  0.1 .05
Cyanotic arm
discoloration 22 1.4  0.2 19 1.3  0.1 .05
Dyspnea at rest 16 1.2  0.1 21 1.4  0.1 .05
Excess sweating, face 13 1.3  0.2 19 1.4  0.1 .05
Enlarged veins,
shoulder 16 1.3  0.2 17 1.3  0.1 .05
Drooping eyelid 6 1.1  0.0 9 1.1  0.0 .05
Finger ulceration 3 1.0  0.0 4 1.1  0.0 .05
aData shown represent the percentage of patients describing each of the
symptoms indicated, and the score indicates the mean  standard error of
the mean for each symptom as scored on a 1-to-5 symptom severity scale
(1  absent, 5  extreme).
bComparison between adolescent (aged 21 years) and adult (aged 21
years) groups, unpaired two-tailed t-test with Welch correction.74.5  2.4), but there was no difference in mean preoper- itive VAS pain scores (Table III). The mean preoperative
TOS Index (a composite of the DASH, CBSQ, and VAS
cores) was also significantly lower in adolescent vs adult
atients (46.5  3.6 vs 58.5  1.7; Table III).
As summarized in Table IV, 75 of 189 patients (39.7%)
sed opiate pain medications before surgical treatment,
ncluding 46 (24.3%) using moderate opiates, 27 (14.3%)
sing strong opiates, and nine (4.8%) using both moderate
nd strong opiates. There was a significant difference in
verall use of opiate pain medications between the adoles-
ent and adult groups (17.1% vs 44.8%) but no differences
able III. Functional assessment and outcome measures
ssessmenta Adolescent Adult Pb
ASH score (scale 0-100)
Preoperative score 35.4  2.9 49.7  1.7 .0001
3-month score 16.7  4.1 41.2  2.1 .0001
6-month score 7.8  3.2 37.8  2.4 .0001
BSQ score (scale 0-120)
Preoperative score 57.3  5.5 74.5  2.4 .0070
3-month score 21.2  6.0 46.5  3.1 .0008
6-month score 11.9  4.4 49.0  3.4 .0001
AS pain score (scale 0-10)
Preoperative score 5.8  0.4 6.3  0.2 .05
3-month score 2.3  0.5 4.4  0.2 .0006
6-month score 1.8  0.5 4.6  0.6 .0006
TOS index (scale 0-100)
Preoperative score 46.5  3.6 58.5  1.7 .0089
3-month score 18.4  4.1 41.0  2.3 .0001
6-month score 10.4  3.1 39.3  3.3 .0001
BSQ,Cervical-brachial symptom questionnaire;DASH, disabilities of arm,
houlder and hand; NTOS, neurogenic thoracic outlet syndrome combined
ith CBSQ, DASH, and VAS; VAS, visual analog scale.
Data shown represent the mean  standard error off the mean.
Comparison between adolescent (aged 21 years) and adult (aged 21
ears) groups, unpaired two-tailed t-test with Welch correction.
able IV. Use of opiate pain medications
ariable
Adolescent
No. (%)
Adult
No. (%) Pa
nitial (preoperative)
None 29 (82.9) 85 (55.2) .0022
Moderateb 4 (11.4) 38 (24.7) .05
Strongc 2 (5.7) 21 (13.6) .05
Moderate  strong 0 (0.0) 10 (6.5) .05
-month follow-up
None 24 (68.6) 53 (34.4) .0003
Moderateb 2 (5.7) 11 (7.1) .05
Strongc 8 (22.9) 74 (48.1) .0078
Moderate  strong 1 (2.9) 16 (10.4) .05
-month follow-up
None 31 (88.6) 81 (52.6) .0001
Moderateb 1 (2.9) 15 (9.7) .05
Strongc 3 (8.6) 48 (31.2) .0057
Moderate  strong 0 (0.0) 10 (6.5) .05
Comparison between adolescent (21 years of age) and adult (21 years of
ge) groups, Fisher exact test for categoric data.
U.S. Drug Enforcement Administration schedules III and IV narcotic
ediations.
U.S. Drug Enforcement Administration schedule II narcotic medications.n the types of medications used.
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January 2013154 Caputo et alSurgical treatment. All patients in this series under-
went supraclavicular decompression without intraoperative
complications. As summarized in Table V, an additional
infraclavicular incision was used in 21 patients (11.1%) to
permit complete resection of the anteromedial first rib for
coexisting vascular compression, with no difference be-
tween the adolescent and adult groups. Ipsilateral PMTwas
performed in conjunction with supraclavicular decompres-
sion in 131 patients (69.3%) and somewhat less frequently
in adolescent patients than in adults (51.4% vs 73.4%).
Contralateral PMT was also performed simultaneously in
18 patients (9.5%), with no difference between adolescent
patients and adults.
The overall postoperative length of hospital stay was
4.8  0.1 days and was significantly less in adolescent
patients than in adults (4.4  0.2 vs 4.9  0.1 days; Table
V). The overall rate of postoperative complications requir-
ing reoperation was 4.2% (one surgical site bleeding, two
infected wound fluid collections, and five persistent lymph
drainage) but was not significantly different between ado-
lescent patients (1 of 35, 2.9%) and adults (7 of 154, 4.5%;
Table V).
Postoperative outcomes. Patients undergoing supra-
clavicular decompression for NTOS exhibited significant
and progressive improvement in symptoms and functional
outcome measures at the 3-month and 6-month follow-up
intervals (Table III; Fig 2). By direct comparison with
adults at the 3-month follow-up, adolescent patients had a
significantly lower mean NTOS Index (18.4  4.1 vs
41.0  2.3l; Table III; Fig 2), and a significantly lower
proportion were using opiate pain medications (31.4% vs
65.6%; Table IV). Adolescent patients also had a signifi-
cantly lower mean NTOS Index than adults at the 6-month
follow-up (10.4 3.1 vs 39.3 3.3; Table III; Fig 2), and
there was a lower proportion using opiate pain medications
Table V. Surgical treatment
Variablesa Adolescent Adult Pb
Supraclavicular incision 29 (82.9) 139 (90.3) .05
plus infraclavicular
incision 6 (17.1) 15 (9.7) .05
PMT included
Ipsilateral 18 (51.4) 113 (73.4) .0148
Contralateral 2 (5.7) 16 (10.4) .05
Hospital length of stay,
days
Mean  SEM 4.4  0.2 4.9  0.1 .0330
Median (range) 4.1 (2.8-7.5) 4.4 (2.0-11.3)
Complications 1 (2.9) 7 (4.5) .05
Bleeding/hematoma 0 (0.0) 1 (0.6) .05
Lymph leak 0 (0.0) 5 (3.2) .05
Wound infection 1 (2.9) 1 (0.6) .05
PMT, Pectoralis minor tenotomy; SEM, standard error of the mean.
aCategoric data shown as number (%), continuous data as indicated.
bComparison between adolescent (aged 21 years) and adult (aged 21
years) groups, unpaired two-tailed t-test with Welch correction (for contin-
uous data) or Fisher exact test (for categoric data).(11.4% vs 47.4%; Table IV). There was a significant corre- tation between age and NTOS Index at the 3-month and
-month intervals after surgical treatment (Fig 3). As
hown in Fig 4 and summarized in Table VI, there was an
verall extent of improvement in the four functional out-
omes measures, ranging from 43.5% to 57.8% in adoles-
ent patients and from 8.7% to 30.0% in adults at 3 months
nd from 63.9% to 83.4% (adolescent patients) and from
2.6% to 29.6% (adults) at 6 months. The overall percent-
ge of patients exhibiting an improvement in outcome
easure scores was from 73.3% to 88.2% (adolescent pa-
ients) and 67.0% to 79.8% (adults) at 3 months and from
6.7% to 100.0% (adolescent patients) and 68.9% to 83.8%
adults) at 6 months. By these analyses, the measured
xtent of improvement at each follow-up interval was con-
istently greater in adolescent patients than in adults, but
here were no significant differences between groups in the
roportion of patients exhibiting improvement (Table VI;
ig 4).
ISCUSSION
The diagnosis and management of NTOS varies widely
etween different physicians and institutions, and deter-
ining the most effective approach to this condition con-
inues to elicit substantial controversy.17 Although the
athophysiologic mechanisms underlying the development
f NTOS have yet to be fully elucidated, it is clear that
ertain patient populations do not improve sufficiently with
onservative management alone. In the present study, we
emonstrate that adolescent and adult patients with dis-
bling NTOS can both improve substantially after surgical
ig 2. Neurogenic thoracic outlet syndrome (NTOS) index
cores are shown for patients undergoing supraclavicular decom-
ression for NTOS, comparing preoperative values with those at
-month and 6-month follow-up intervals (data shown represent
he mean  standard error of the mean). Line graphs depicting
omparison between adolescent patients and adults demonstrate a
ignificant and progressive decline in NTOS Index scores during
ostoperative follow-up in both groups with a more rapid and
ubstantial decline in adolescent patients vs adults (P  .0001
ne-way ANOVA). *P  .001 (Newman-Keuls multiple compar-
sons test; NS  not significant (P  .05). **P  .05, adolescent
atients vs adults at each interval, unpaired two-tailed t-test with
elch correction.reatment. This reinforces the notion that surgical treat-
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Volume 57, Number 1 Caputo et al 155ment of NTOS is effective in the adolescent age group and
helps to identify clinical factors that may be associated with
more favorable outcomes in other patients.
Several reports have been published concerning TOS in
pediatric and adolescent patients.18-23 Although these
studies have provided valuable insights, the relatively low
numbers of patients with NTOS prevents meaningful con-
clusions to be drawn regarding optimal management of this
condition in children and young adults. There appears to be
an overall benefit to those patients undergoing surgical
decompression, but there is inconsistency in diagnostic
criteria, limited clinical follow-up, and minimal use of
quantifiable outcomemeasures to assess management strat-
egies. Previous studies are also confounded by the use of
different surgical approaches, inclusion of primary vascular
forms of TOS, and lack of comparison groups. As noted by
Stansby and Lambert,24 although comparative clinical trials
on the management of TOS are somewhat unrealistic,
establishment of a TOS registry to record indications,
Fig 3. Age and postoperative functional outcome meas
and neurogenic thoracic outlet syndrome (NTOS) ind
postoperative follow-up. P  .0022, Pearson correlation
follow-up. P  .0026, Pearson correlation test (r  .305outcomes and complications, accompanied by national so- ciety guidelines, would be a worthwhile and valuable en-
eavor in this field.
In the present report, we assessed 189 patients who
nderwent supraclavicular decompression for disabling
TOS that had been refractory to conservative manage-
ent. Of these patients, 35 were aged 21 years, thereby
epresenting the largest group of pediatric or adolescent
atients with NTOS described in the literature to date.
urthermore, our comparison group was a cohort of 154
dults who underwent a similar approach to surgical de-
ompression for NTOS in the same time period. In exam-
ning the preoperative clinical characteristics between the
wo groups, we found that patients in the adolescent cohort
ad a significantly lower incidence of depression and history
f motor vehicle injury, and a higher incidence of repetitive
otion injury and participation in athletics. The overall
uration of symptoms was shorter for adolescent patients
ompared with adults, and previous use of opiate pain
edications was also substantially lower. These favorable
Scatterplots depict the relationship between patient age
ores during postoperative follow-up. A, Three-month
(r  .2825; R2  .0798). B, Six-month postoperative
2  .0931).ures.
ex sc
testlinical features in adolescent patients can thereby be ex-
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ment compared with adults.
We used several patient-reported survey instruments to
assess preoperative characteristics of individuals with
NTOS and to provide quantifiable outcome measures of
treatment results. Prior to treatment, adolescent patients
had significantly lower scores for the DASH, CBSQ, and
NTOS index compared with adults (but no difference in
VAS pain scores). Using these measures as well as descrip-
tive evaluations of symptoms, adolescent and adult patients
both exhibited significant improvement 3 months after
supraclavicular decompression, with slightly greater (but
not statistically significant) improvement at 6 months. The
extent of improvement at both intervals was greater in
adolescent patients than adults, with significantly lower
scores for the DASH, CBSQ, and NTOS index, and ado-
lescent patients also had lower use of opiate pain medica-
tions than adults at both the 3-month and 6-month follow-
up. These findings were further reflected by a linear
correlation between age and NTOS index at both 3 and 6
months of follow-up. Although these results confirm that
supraclavicular decompression is successful in treating dis-
ablingNTOS, they indicate that adolescent patients tend to
have greater improvement, as determined by quantitative
functional outcome measures, compared with adults.
One limitation of this investigation is that during the
time interval over which the study patients underwent
treatment, we did not regularly use quality-of-life measures,
such as those previously described in patients with TOS by
Chang et al.25 Obtaining this type of information is now
Fig 4. Postoperative improvement in functional outcome mea-
sures. The extent (percentage) of improvement in the neurogenic
thoracic outlet syndrome (NTOS) index at 3months and 6months
for patients undergoing supraclavicular decompression for NTOS,
with data shown for adolescent patients and adults (values repre-
sent the mean  standard error of the mean). Inset values depict
the overall percentage of patients exhibiting improvement.included in our approach to patient assessment before and tfter treatment and will provide useful information in the
uture. In addition to a relatively large number of patients
ith NTOS, strengths of this study include the consistency
f clinical management throughout the period of review.
hus, all patients underwent surgical treatment in a similar
anner by a single surgeon, with protocol-driven care
rovided through the operating room, inpatient hospital
tay, and postoperative phases of care.
Other limitations of this study include its retrospective
ature as well as the absence of a cohort of patients man-
ged conservatively for NTOS. Although all of the patients
nderwent surgery after failing to improve with appropriate
OS-specific physical therapy, we do not otherwise know
he number of patients with NTOS from the same popula-
ion base that might have been treated successfully with
onservative measures alone.
ONCLUSIONS
We found that adolescent patients had more favorable
linical characteristics at the time of referral, which ap-
eared to predict better outcomes than adults after surgical
reatment. Further study may reveal that one or more of
hese clinical characteristics, alone or in various combina-
ions, can effectively predict response to treatment in
dults. However, because the duration of symptoms was
lso shorter in adolescent patients, we are unable to exclude
able VI. Postoperative outcomes at 3 and 6 months
utcome Adolescent (%) Adult (%) Pa
-month follow-up
Percent improvement
DASH score 43.5  15.5 8.7  8.0 .05
CBSQ score 56.8  14.1 15.1  15.0 .0475
VAS pain score 56.3  11.5 20.3  7.5 .0140
NTOS index 57.8  11.3 30.0  4.1 .0364
Percent of patients
improved
DASH score 85.0 67.0 .05
CBSQ score 88.2 79.8 .05
VAS pain score 73.3 69.1 .05
NTOS index 76.9 76.5 .05
-month follow-up
Percent improvement
DASH score 79.5  9.2 20.6  6.4 .0001
CBSQ score 83.4  5.9 17.3  17.0 .0004
VAS pain score 63.9  9.6 12.6  16.4 .0086
NTOS index 78.0  6.0 29.6  7.3 .0001
Percent of patients
improved
DASH score 93.8 68.9 .0399
CBSQ score 100.0 82.6 .05
VAS pain score 86.7 69.2 .05
NTOS index 100.0 83.8 .05
BSQ, Cervical-Brachial Symptom Questionnaire; DASH, Disabilities of
he Arm, Shoulder and Hand; NTOS Index, neurogenic thoracic outlet
yndrome assessed by combined CBSQ, DASH, and VAS pain score.
Comparison between adolescent (aged 21 years) and adult (aged 21
ears) groups, unpaired two-tailed t-test with Welch correction (for contin-
ous data) or Fisher exact test (for categoric data).he possibility that age may simply represent a surrogate for
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Volume 57, Number 1 Caputo et al 157earlier diagnosis and referral rather than a completely inde-
pendent prognostic factor in determining responsiveness to
treatment. Finally, the period of postoperative follow-up in
the present study was limited to 6 months. Because the
incidence of recurrent NTOS appears to be greatest within
the first 2 years after surgical treatment, the duration of
follow-up reported here may not have taken into account
the potential development of recurrent NTOS or the need
for reoperative procedures at later intervals.26,27 Additional
investigations will therefore be needed to further delineate
the age-dependent and independent factors that promote
optimal surgical outcomes for NTOS.
The authors are indebted to Verdella F. Brink, Yvette
Blakemore, and Robert Fuller, RMA, for helping care for
our patients with thoracic outlet syndrome.
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